Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Chuaqui

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Pyrazolone based TGFbetaR1 kinase inhibitorsKevin Guckian, Mary Beth Carter, Edward Yin-Shiang Lin, et al.
ACS Chemical Biology|July 31, 2013
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1Jiaquan Wu, Keith Mikule, Wenxian Wang, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M MutationEdward J Hennessy, Claudio Chuaqui, Susan Ashton, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinasesTao Wang, Michael A Block, Scott Cowen, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 InhibitorsWilliam McCoull, Edward J Hennessy, Kevin Blades, et al.
Journal of Medicinal Chemistry|December 24, 2013
Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitorsQibin Su, Stephanos Ioannidis, Claudio Chuaqui, et al.
Journal of Medicinal Chemistry|December 3, 2014
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screeningBin Yang, Michelle L Lamb, Tao Zhang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
Journal of Medicinal Chemistry|November 2, 2021
Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7Jason J Marineau, Kristin B Hamman, Shanhu Hu, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|November 17, 2009
Pyrazolone based TGFbetaR1 kinase inhibitorsKevin Guckian, Mary Beth Carter, Edward Yin-Shiang Lin, et al.
ACS Chemical Biology|July 31, 2013
Discovery and mechanistic study of a small molecule inhibitor for motor protein KIFC1Jiaquan Wu, Keith Mikule, Wenxian Wang, et al.
ACS Medicinal Chemistry Letters|May 19, 2016
Utilization of Structure-Based Design to Identify Novel, Irreversible Inhibitors of EGFR Harboring the T790M MutationEdward J Hennessy, Claudio Chuaqui, Susan Ashton, et al.
ACS Medicinal Chemistry Letters|March 18, 2016
Potent and Selective CK2 Kinase Inhibitors with Effects on Wnt Pathway Signaling in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
Bioorganic & Medicinal Chemistry Letters|February 7, 2012
Discovery of azabenzimidazole derivatives as potent, selective inhibitors of TBK1/IKKε kinasesTao Wang, Michael A Block, Scott Cowen, et al.
ACS Medicinal Chemistry Letters|December 21, 2016
Optimization of Highly Kinase Selective Bis-anilino Pyrimidine PAK1 InhibitorsWilliam McCoull, Edward J Hennessy, Kevin Blades, et al.
Journal of Medicinal Chemistry|December 24, 2013
Discovery of 1-methyl-1H-imidazole derivatives as potent Jak2 inhibitorsQibin Su, Stephanos Ioannidis, Claudio Chuaqui, et al.
Journal of Medicinal Chemistry|December 3, 2014
Discovery of potent KIFC1 inhibitors using a method of integrated high-throughput synthesis and screeningBin Yang, Michelle L Lamb, Tao Zhang, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Structure and Property Based Design of Pyrazolo[1,5-a]pyrimidine Inhibitors of CK2 Kinase with Activity in VivoJames E Dowling, Marat Alimzhanov, Larry Bao, et al.
Journal of Medicinal Chemistry|November 2, 2021
Discovery of SY-5609: A Selective, Noncovalent Inhibitor of CDK7Jason J Marineau, Kristin B Hamman, Shanhu Hu, et al.
Pageof 3